Azura Ophthalmics
AcquiredTel Aviv, Israel · $36.0M raised
- Headquarters
- Tel Aviv
- Employees
- 1–10
- Business Model
- B2B
- Website
- azuraophthalmics.com
- Total Funding
- $36.0M
- Last Round
- $20.0M Series COct 2020
- Rounds
- 3
About
Clinical-stage biotech developing ophthalmic keratolytic therapies targeting meibomian gland dysfunction and ocular surface diseases.
Summary
Azura Ophthalmics is a Biotech company based in Tel Aviv, Israel. It has raised $36.0M in total across 3 rounds, most recently a $20.0M Series C round in Oct 2020. Investors include OrbiMed, Brandon Capital Partners and TPG Biotech.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...